FDA Grants Accelerated Approval to Teplizumab for Newly Diagnosed Pediatric Type 1 Diabetes
As shared in a recent press release, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to teplizumab (Tzield) for a new pediatric indication, marking a major development…